Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

74.46 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H.... 
Via Benzinga
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations 
Via MarketBeat
Demystifying DexCom: Insights From 15 Analyst Reviews
Via Benzinga
Behind the Scenes of DexCom's Latest Options Trends
Via Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. 
Via Chartmill
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
Via Investor's Business Daily
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Top 3 Health Care Stocks That May Explode In Q3
Via Benzinga
NASDAQ: DXCM Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Market Momentum: Your Weekly Financial Forecast
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024 
Via Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now. 
Via The Motley Fool
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
Via Benzinga
Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - July 29, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
Is Beaten-Down Dexcom Stock a Buy on the Dip?
The market may have overreacted to a disappointing earnings report. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
These profitable businesses have a lot to offer the long-term investor. 
Via The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kaplan Fox &amp; Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
NEW YORK, NY - (NewMediaWire) - July 28, 2024 -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
2 Magnificent Growth Stocks to Buy Right Now
These top stocks are looking increasingly attractive for a long-term investment. 
Via The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kaplan Fox &amp; Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
NEW YORK, NY - (NewMediaWire) - July 26, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DXCM INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into DexCom, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DexCom, Inc. (DXCM)
From Kirby McInerney LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.